Veterinary Medicines

DALMARELIN 25 micrograms/ml solution for injection for cattle and rabbits

Authorised
  • Lecirelin
Download as PDF

Product identification

Medicine name:
DALMARELIN 25 micrograms/ml solution for injection for cattle and rabbits
Dalmarelin vet 25 mikrogram/ml injektionsvätska, lösning för nötkreatur och kanine
Active substance:
  • Lecirelin
Target species:
  • Rabbit
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lecirelin
    25.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Rabbit
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA92
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:
  • 4 ml type I or type II neutral colourless glass vials, closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.
  • 10 x 4 ml type I or type II neutral colourless glass vials, closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.
  • 10 ml type I or type II neutral colourless glass vials, closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.
  • 5 x 10 ml type I or type II neutral colourless glass vials, closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.
  • 20 ml type I or type II neutral colourless glass vials, closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.
  • 100 ml High Density Polyethylene (HDPE) collapsible container closed with a type I rubber stopper and an aluminium overseal, in a cardboar box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 62988
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0112/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Iceland
  • Ireland
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 25/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."